{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:02:21Z","timestamp":1760659341035,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clindermatol.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T17:17:04Z","timestamp":1628443024000},"page":"64-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lasers, lights, and compounds for hair loss in aesthetics"],"prefix":"10.1016","volume":"40","author":[{"given":"Christina M.","family":"Ring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Finney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Avram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.08.013_bib0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639709160517","article-title":"Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course","volume":"8","author":"Mazzarella","year":"1997","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0002","first-page":"881","article-title":"Randomized double-blind placebo controlled trial in the treatment of male andro-genetic alopecia with 0.1% finasteride solution","volume":"113","author":"Charuwichitratana","year":"2003","journal-title":"J Dermatol"},{"year":"2006","series-title":"Clinical Evaluation of Topical Formulation of Finasteride in Male Androgenetic Alopecia","author":"Sitticharoenchai","key":"10.1016\/j.clindermatol.2021.08.013_bib0003"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0378-6323.45220","article-title":"Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia","volume":"75","author":"Hajheydari","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0005","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"A Randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia","volume":"32","author":"Suchonawanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","article-title":"Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study","volume":"20","author":"Suchonawanit","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0007","doi-asserted-by":"crossref","first-page":"842","DOI":"10.5414\/CP202119","article-title":"A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers","volume":"52","author":"Caserini","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jocd.12541","article-title":"Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: a randomized, placebo-controlled, double-blind, noninferiority study","volume":"18","author":"Blume-Peytavi","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546634.2017.1330527","article-title":"Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata","volume":"29","author":"El-Ashmawy","year":"2018","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-4632.2007.03119.x","article-title":"Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro","volume":"46","author":"Fischer","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0011","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/bjd.13114","volume":"171","author":"Fischer","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0012","first-page":"69","article-title":"Clinical efficacy of a topical compounded formulation in male androgenetic alopecia: minoxidil 10%, finasteride 0.1%, biotin 0.2%, and caffeine citrate 0.05% hydroalcoholic solution","volume":"24","author":"Marotta","year":"2020","journal-title":"Int J Pharm Compd"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000101389","article-title":"Follicular penetration of topically applied caffeine via a shampoo formulation","volume":"20","author":"Otberg","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0014","first-page":"492","article-title":"Efficacy of a cosmetic phyto-caffeine Shampoo in female androgenetic alopecia","volume":"155","author":"Bussoletti","year":"2020","journal-title":"G Ital Dermatol Venerol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdcr.2019.12.008","article-title":"Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin","volume":"22","author":"Araoye","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fertnstert.2019.11.030","article-title":"Post-finasteride syndrome: a surmountable challenge for clinicians","volume":"113","author":"Traish","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0017","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jsxm.2016.07.006","article-title":"Effect of 5\u03b1-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials","volume":"13","author":"Liu","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0018","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"PLESS Study Group. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessells","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0019","doi-asserted-by":"crossref","first-page":"I5047","DOI":"10.1136\/bmj.l5047","article-title":"Post-finasteride syndrome","volume":"366","author":"Gray","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0020","doi-asserted-by":"crossref","first-page":"djw168","DOI":"10.1093\/jnci\/djw168","article-title":"Long-term consequences of finasteride vs placebo in the Prostate Cancer Prevention Trial","volume":"108","author":"Unger","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000450617","article-title":"Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome","volume":"2","author":"Fertig","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0022","first-page":"414","article-title":"Side effects related to 5 \u03b1-reductase inhibitor treatment of hair loss in women: a review","volume":"15","author":"Seale","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0023","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/ijd.14370","article-title":"The efficacy and use of finasteride in women: a systematic review","volume":"58","author":"Hu","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0024","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D32311037240","article-title":"Sexual side effects of 5-\u03b1-reductase inhibitors finasteride and dutasteride: a comprehensive review","volume":"23","author":"Fertig","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0025","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","article-title":"Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia","volume":"81","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2021.08.013_bib0026","first-page":"AB113","article-title":"Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia","volume":"72","author":"Lueangarun","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0027","doi-asserted-by":"crossref","first-page":"e12707","DOI":"10.1111\/dth.12707","article-title":"Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the Five C's of oral therapy","volume":"31","author":"Beach","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0028","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0029","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1203475419879887","article-title":"Oral minoxidil: a possible new therapy for androgenetic alopecia","volume":"24","author":"Gomolin","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2891-10-20","article-title":"Use of dietary supplements by cardiologists, dermatologists and orthopedists: report of a survey","volume":"10","author":"Dickinson","year":"2011","journal-title":"Nutr J"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0031","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaad.2018.12.045","article-title":"Assessment of biotin supplementation among patients in an outpatient dermatology clinic","volume":"81","author":"John","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0032","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0033","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jaad.2018.02.018","article-title":"Rethinking biotin therapy for hair, nail, and skin disorders","volume":"78","author":"Lipner","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0034","first-page":"s141","article-title":"A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals","volume":"16","author":"Farris","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0035","first-page":"1001","article-title":"Stress and the hair growth cycle: cortisol-induced hair growth disruption","volume":"15","author":"Thom","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0036","first-page":"50","article-title":"A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study","volume":"11","author":"Auddy","year":"2008","journal-title":"J Am Nutraceut Assoc"},{"year":"2005","series-title":"Dietary Supplements: A Framework for Evaluating Safety","key":"10.1016\/j.clindermatol.2021.08.013_bib0037"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0038","first-page":"558","article-title":"A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair","volume":"17","author":"Ablon","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/841570","article-title":"A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair","volume":"2015","author":"Ablon","year":"2015","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jocd.12265","article-title":"A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair","volume":"15","author":"Ablon","year":"2016","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0041","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/DSS.0000000000002147","article-title":"The physician's guide to platelet-rich plasma in dermatologic surgery part I: definitions, mechanisms of action, and technical specifications","volume":"46","author":"Hausauer","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0042","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1524-4725.2012.02394.x","article-title":"Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth","volume":"38","author":"Li","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0043","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0044","doi-asserted-by":"crossref","first-page":"3","DOI":"10.32098\/mltj.01.2014.02","article-title":"Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives","volume":"4","author":"Dohan Ehrenfest","year":"2014","journal-title":"Muscles Ligaments Tendons J"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2015-000060","article-title":"DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices","volume":"2","author":"Magalon","year":"2016","journal-title":"BMJ Open Sport Exerc Med"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0046","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/DSS.0000000000001965","article-title":"Platelet-rich plasma and its utilities in Alopecia: a systematic review","volume":"46","author":"Hesseler","year":"2019","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0047","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.12397","article-title":"A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata","volume":"169","author":"Trink","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0048","first-page":"118","article-title":"Intralesional platelet rich plasma vs intralesional triamcinolone in the treatment of alopecia areata: a comparative study","volume":"4","author":"Shumez","year":"2015","journal-title":"Int J Med Res Heal Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0049","doi-asserted-by":"crossref","first-page":"e12437","DOI":"10.1111\/dth.12437","article-title":"Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation","volume":"30","author":"El Taieb","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5966\/sctm.2015-0107","article-title":"The effect of platelet- rich plasma in hair regrowth: a randomized placebo-controlled trial","volume":"4","author":"Gentile","year":"2015","journal-title":"Stem Cell Transl Med"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0051","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jocd.12357","article-title":"The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study","volume":"17","author":"Tawfik","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0052","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms18020408","article-title":"Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems","volume":"18","author":"Gentile","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0053","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/JCAS.JCAS_50_16","article-title":"A spilt head study of efficacy of placebo versus platelet-rich plasma injections in the treatment of androgenic alopecia","volume":"10","author":"Kachhawa","year":"2017","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0054","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/wrr.12250","article-title":"Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss","volume":"23","author":"Lee","year":"2015","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0055","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DSS.0000000000000883","article-title":"Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia","volume":"42","author":"Puig","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0056","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/idoj.IDOJ_11_17","article-title":"Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment?","volume":"8","author":"Ayatollahi","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0057","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/14764172.2016.1225963","article-title":"Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial","volume":"18","author":"Mapar","year":"2016","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0058","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jocd.12394","article-title":"Original article: platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation","volume":"17","author":"Jha","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0059","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DSS.0000000000001198","article-title":"Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia","volume":"44","author":"Alves","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/DSS.0000000000001049","article-title":"The effect of plasma rich in growth factors on pattern hair loss","volume":"43","author":"Anitua","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0061","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/DSS.0000000000000904","article-title":"A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss","volume":"43","author":"Gupta","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0062","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D3252042885","article-title":"Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma\u2013with or without concurrent bimatoprost and\/or minoxidil","volume":"25","author":"Cohen","year":"2019","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0063","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.det.2012.08.018","article-title":"Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis","volume":"31","author":"Kalia","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0064","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1038\/srep30540","article-title":"Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/pho.2005.23.355","article-title":"Exact action spectra for cellular responses relevant to phototherapy","volume":"23","author":"Karu","year":"2005","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0066","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10103-015-1775-9","article-title":"Evaluation of wavelength-dependent hair growth effects on low-level laser therapy: an experimental animal study","volume":"30","author":"Kim","year":"2015","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0067","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10103-019-02723-6","article-title":"Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials","volume":"34","author":"Liu","year":"2019","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0068","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/ijdvl.IJDVL_1156_16","article-title":"The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia","volume":"84","author":"Faghihi","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0069","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s10103-017-2306-7","article-title":"Efficacy of fractional lasers in treating alopecia: a literature review","volume":"32","author":"Perper","year":"2017","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0070","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1468-3083.2011.04183.x","article-title":"The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss","volume":"25","author":"Lee","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0071","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4725.2010.01833.x","article-title":"Fractional photothermolysis laser treatment of male pattern hair loss","volume":"37","author":"Kim","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0072","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4172\/2471-9323.1000108","article-title":"Alopecia areata: good response to treatment with fractional laser in 5 cases","volume":"2","author":"Eckert","year":"2016","journal-title":"J Cosmo Trichol"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0073","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/DSS.0000000000000649","article-title":"The effect of neodymium: yttrium aluminum garnet and fractional carbon dioxide lasers on alopecia areata: a prospective controlled clinical trial","volume":"42","author":"Yalici-Armagan","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0074","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/14764172.2013.764436","article-title":"Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients","volume":"15","author":"Cho","year":"2013","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0075","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1002\/jps.24143","article-title":"Erbium-yttrium- aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs","volume":"103","author":"Lee","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0076","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15171\/jlms.2020.06","article-title":"The effect of the fractional carbon dioxide laser on improving minoxidil delivery for the treatment of androgenetic alopecia","volume":"11","author":"Salah","year":"2020","journal-title":"J Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0077","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s10103-017-2232-8","article-title":"Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors","volume":"32","author":"Huang","year":"2017","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0078","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/ced.13551","article-title":"A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss","volume":"43","author":"Yu","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2021.08.013_bib0079","first-page":"S158","article-title":"Hair transplantation controversies","volume":"43","author":"MR","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2021.08.013_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0974-2077.191657","article-title":"Outcome of intra-operative injected platelet-rich plasma therapy during follicular unit extraction hair transplant: a prospective randomised study in forty patients","volume":"9","author":"Garg","year":"2016","journal-title":"J Cutan Aesthet Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:58Z","timestamp":1760033878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0738081X21001693"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.08.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lasers, lights, and compounds for hair loss in aesthetics","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}